In adult T-cell leukemia/lymphoma (ATL), JAK3 FERM domain mutations have been shown to induce gain of function in JAK3 and to activate JAK3 in vitro [94]. The gene discussed is JAK3; the disease is adult T-cell leukemia/lymphoma.